These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5831004)

  • 1. [Antitubercular activity of ethambutol studies "in vitro" in monocyte culture of mycobacteria].
    Grassi C; Mammarella E
    G Ital Chemioter; 1964; 11(4):149-52. PubMed ID: 5831004
    [No Abstract]   [Full Text] [Related]  

  • 2. [The in vitro effect of ethambutol on atypical mycobacteria].
    Goda K; Sakamoto T
    Kekkaku; 1965 May; 40(5):154-7. PubMed ID: 5853349
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of Ethambutol [d-2,2'-(ethylenediimino)-di-I-butanol] resistant mycobacteria grown in the absence of Ethambutol.
    Gupta SK; Mathur IS
    Indian J Exp Biol; 1965 Jul; 3(3):176-7. PubMed ID: 5320364
    [No Abstract]   [Full Text] [Related]  

  • 4. [Susceptibility of various mycobacteria to ethambutol--with reference to the differentiation between M. avium and M. terrae].
    Mizuno S; Toyama H; Tsukamura M
    Nihon Saikingaku Zasshi; 1966 Nov; 21(11):672-4. PubMed ID: 6010588
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental research on the antimycobacterial activity of ethambutol].
    Lucchesi M; Zubiani M; Termine A; Mancini P
    Ann Ist Carlo Forlanini; 1966; 26(1):41-53. PubMed ID: 5919238
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quality control of culture media for mycobacterium drug sensitivity tests].
    Kekkaku; 2003 Aug; 78(8):563-8. PubMed ID: 14582504
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.
    Heginbothom ML
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):539-45. PubMed ID: 11409581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ethambutol on Mycobacteria.
    Forbes M; Peets EA; Kuck NA
    Ann N Y Acad Sci; 1966 Apr; 135(2):726-31. PubMed ID: 5220238
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of thioridazine against mycobacteria.
    van Ingen J; van der Laan T; Amaral L; Dekhuijzen R; Boeree MJ; van Soolingen D
    Int J Antimicrob Agents; 2009 Aug; 34(2):190-1. PubMed ID: 19346105
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro drug sensitivity of M. avium-intracellulare complex in the presence and absence of dimethyl sulphoxide.
    Nash DR; Steingrube VA
    Microbios; 1982; 35(140):71-8. PubMed ID: 7162431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ostruthin: an antimycobacterial coumarin from the roots of Peucedanum ostruthium.
    Schinkovitz A; Gibbons S; Stavri M; Cocksedge MJ; Bucar F
    Planta Med; 2003 Apr; 69(4):369-71. PubMed ID: 12709907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Method of in vitro study of the sensitivity of mycobacteria to 4,4'-diisoamyloxythiocarbanilide (Isoxyl)].
    Tacquet A; Roos P; Devulder B; Martin G
    Ann Inst Pasteur Lille; 1965; 16():31-6. PubMed ID: 5895723
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cyclic analogs of ethambutol with antimycobacterial activity].
    Berthelot P; Debaert M; Cremieux A; Baghadi N
    Farmaco Sci; 1983 Feb; 38(2):73-80. PubMed ID: 6840268
    [No Abstract]   [Full Text] [Related]  

  • 17. [D-2, 2'-(ethylenediimino)-di-1-butanol therapy on pulmonary disease caused by "unclassified" mycobacteria (nonphotochromogen)].
    Baba M
    Kekkaku; 1965 Dec; 40(12):551-4. PubMed ID: 5886180
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistance of strains of atypical mycobacteria to chemo-antibiotics, with special attention to the so-called minor antitubercular drugs].
    Vercellino E
    G Mal Infett Parassit; 1968 Feb; 20(2):195-6. PubMed ID: 5741087
    [No Abstract]   [Full Text] [Related]  

  • 19. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of conformationally constrained analogues of the antitubercular agent ethambutol.
    Faugeroux V; Génisson Y; Salma Y; Constant P; Baltas M
    Bioorg Med Chem; 2007 Sep; 15(17):5866-76. PubMed ID: 17566744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.